Skip to content
Recall Observatory FDA recall evidence

Drug product

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-738-86

D-0858-2022

April 29, 2022

Class III

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 90088
Status
Terminated
Classification
Class III
Quantity
744 bottles
Official record key
drug-enforcement:D-0858-2022

Official wording

Reason: Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Code information: Lot #: HAC2237A, exp. date 05/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Substance